Michael "Mike" Albert, MD
@michaelalbertmd
Co-Founder, Chief Medical Officer @accomplishhlth | Obesity & Cardiometabolic Medicine | Clinical Incretinology | Healthcare Futurist
ID: 1010678065398087681
https://linktr.ee/MichaelAlbertMD 24-06-2018 00:16:43
20,20K Tweet
13,13K Followers
1,1K Following
Every branded Semaglutide and Tirzepatide pen should be Multi-use. These single-use pens are wasteful and an environmental hazard. Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 On The Pen Beverly G. Tchang, MD #ReleaseMultiusePens #GreenerHealthcare #StopMedicalWaste #ReuseYourPen #EcoFriendlyPharma
Dr. Shun Kohsaka discussed the concept of LDL-years. It’s the ⭐️cumulative LDL exposure⭐️ that determines risk of plaque rupture. Above 5000 LDL-years, the risk of rupture rises exponentially! Gotta start early ⏰ #ESCCongress #ESCPrev European Society of Cardiology Christie Ballantyne
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association Journal of Clinical Lipidology Dan Soffer Christie Ballantyne Jessica Peña Seth Martin - 👏 lipidjournal.com/article/S1933-… Highlights 👉 ➡️ApoB